Signet Financial Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $462K | Sell |
8,363
-201
| -2% | -$10.9K | 0.05% | 217 |
|
|
2025
Q4 | $420K | Sell |
8,564
-125
| -1% | -$5.83K | 0.05% | 217 |
|
|
2025
Q3 | $375K | Sell |
8,689
-78
| -0.9% | -$3.05K | 0.04% | 225 |
|
|
2025
Q2 | $337K | Sell |
8,767
-428
| -5% | -$16.4K | 0.04% | 227 |
|
|
2025
Q1 | $356K | Sell |
9,195
-217
| -2% | -$7.94K | 0.05% | 221 |
|
|
2024
Q4 | $318K | Sell |
9,412
-1,334
| -12% | -$48K | 0.04% | 224 |
|
|
2024
Q3 | $439K | Sell |
10,746
-254
| -2% | -$10.4K | 0.06% | 200 |
|
|
2024
Q2 | $424K | Sell |
11,000
-162
| -1% | -$6.82K | 0.06% | 199 |
|
|
2024
Q1 | $479K | Buy |
11,162
+494
| +5% | +$20.4K | 0.07% | 200 |
|
|
2023
Q4 | $395K | Sell |
10,668
-291
| -3% | -$10.4K | 0.06% | 208 |
|
|
2023
Q3 | $397K | Sell |
10,959
-1,494
| -12% | -$53K | 0.07% | 201 |
|
|
2023
Q2 | $444K | Sell |
12,453
-282
| -2% | -$10.1K | 0.07% | 201 |
|
|
2023
Q1 | $453K | Sell |
12,735
-437
| -3% | -$15.3K | 0.08% | 198 |
|
|
2022
Q4 | $463K | Sell |
13,172
-121
| -0.9% | -$4.03K | 0.08% | 193 |
|
|
2022
Q3 | $391K | Sell |
13,293
-108
| -0.8% | -$4.09K | 0.08% | 189 |
|
|
2022
Q2 | $729K | Sell |
13,401
-97
| -0.7% | -$5.36K | 0.14% | 146 |
|
|
2022
Q1 | $735K | Sell |
13,498
-428
| -3% | -$23.2K | 0.12% | 150 |
|
|
2021
Q4 | $768K | Sell |
13,926
-113
| -0.8% | -$5.88K | 0.12% | 144 |
|
|
2021
Q3 | $671K | Sell |
14,039
-290
| -2% | -$14.6K | 0.12% | 143 |
|
|
2021
Q2 | $713K | Sell |
14,329
-360
| -2% | -$17.3K | 0.24% | 69 |
|
|
2021
Q1 | $655K | Buy |
14,689
+134
| +0.9% | +$6.08K | 0.12% | 144 |
|
|
2020
Q4 | $670K | Sell |
14,555
-603
| -4% | -$27.7K | 0.14% | 140 |
|
|
2020
Q3 | $693K | Sell |
15,158
-1,925
| -11% | -$96.4K | 0.15% | 130 |
|
|
2020
Q2 | $874K | Sell |
17,083
-431
| -2% | -$22.1K | 0.19% | 107 |
|
|
2020
Q1 | $924K | Sell |
17,514
-3,438
| -16% | -$183K | 0.22% | 105 |
|
|
2019
Q4 | $1.23M | Buy |
20,952
+61
| +0.3% | +$3.39K | 0.23% | 106 |
|
|
2019
Q3 | $1.16M | Sell |
20,891
-1,080
| -5% | -$55.6K | 0.23% | 107 |
|
|
2019
Q2 | $1.15M | Sell |
21,971
-292
| -1% | -$14.7K | 0.23% | 110 |
|
|
2019
Q1 | $1.13M | Sell |
22,263
-9,234
| -29% | -$461K | 0.22% | 112 |
|
|
2018
Q4 | $1.5M | Buy |
31,497
+99
| +0.3% | +$4.88K | 0.33% | 97 |
|
|
2018
Q3 | $1.58M | Buy |
31,398
+9,096
| +41% | +$462K | 0.28% | 100 |
|
|
2018
Q2 | $1.12M | Sell |
22,302
-320
| -1% | -$16.1K | 0.2% | 110 |
|
|
2018
Q1 | $1.1M | Buy |
+22,622
| New | +$1.05M | 0.2% | 111 |
|
Other funds holding GSK
JEST
Signet Financial Management's GSK Position: Q1 2026 in Review
Signet Financial Management reduced its GSK (GSK) stake by 2.3% in Q1 2026, selling an estimated $10.9K and leaving 8,363 shares worth $462K. The position accounts for 0.05% of the portfolio, ranked #217.
Signet Financial Management first reported a position in GSK in Q1 2018 and has held it in 33 quarters since. The position peaked at $1.58M in Q3 2018. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Signet Financial Management held 8,363 shares of GSK worth $462K as of Q1 2026.
- Signet Financial Management sold 201 GSK shares in Q1 2026, an estimated $10.9K.
- GSK made up 0.05% of Signet Financial Management's portfolio in Q1 2026, its #217 holding.
- Signet Financial Management first reported a position in GSK in Q1 2018 and has held it in 33 quarters since.
- Signet Financial Management's GSK position peaked at $1.58M in Q3 2018.
- 1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.